Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Pharma and Consumer Health613M57.08%
Biologics461M42.92%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.77B64.93%
Europe1.26B29.49%
Other355M8.33%
Elimination of revenue attributable to multiple locations-117M-2.74%
